BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36503956)

  • 1. Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications.
    Vilardaga JP; Clark LJ; White AD; Sutkeviciute I; Lee JY; Bahar I
    Endocr Rev; 2023 May; 44(3):474-491. PubMed ID: 36503956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endosomal parathyroid hormone receptor signaling.
    Peña KA
    Am J Physiol Cell Physiol; 2022 Sep; 323(3):C783-C790. PubMed ID: 35912987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosomal signaling via cAMP in parathyroid hormone (PTH) type 1 receptor biology.
    Peña KA; Savransky S; Lewis B
    Mol Cell Endocrinol; 2024 Feb; 581():112107. PubMed ID: 37981188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G
    White AD; Jean-Alphonse FG; Fang F; Peña KA; Liu S; König GM; Inoue A; Aslanoglou D; Gellman SH; Kostenis E; Xiao K; Vilardaga JP
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7455-7460. PubMed ID: 32184323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of phenylalanine-34 of parathyroid hormone disrupts NHERF1 regulation of PTH type I receptor signaling.
    Wheeler D; Sneddon WB
    Endocrine; 2006 Dec; 30(3):343-52. PubMed ID: 17526947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1R.
    Martin TJ; Sims NA; Seeman E
    Endocr Rev; 2021 Jul; 42(4):383-406. PubMed ID: 33564837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
    Cupp ME; Nayak SK; Adem AS; Thomsen WJ
    J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides.
    Pioszak AA; Parker NR; Gardella TJ; Xu HE
    J Biol Chem; 2009 Oct; 284(41):28382-28391. PubMed ID: 19674967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid Hormone Senses Extracellular Calcium To Modulate Endocrine Signaling upon Binding to the Family B GPCR Parathyroid Hormone 1 Receptor.
    Culhane KJ; Belina ME; Sims JN; Cai Y; Liu Y; Wang PSP; Yan ECY
    ACS Chem Biol; 2018 Aug; 13(8):2347-2358. PubMed ID: 29952553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling.
    Syme CA; Friedman PA; Bisello A
    J Biol Chem; 2005 Mar; 280(12):11281-8. PubMed ID: 15611080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gβγ complex.
    Wehbi VL; Stevenson HP; Feinstein TN; Calero G; Romero G; Vilardaga JP
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1530-5. PubMed ID: 23297229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-selective dissociation of activation and internalization of the parathyroid hormone (PTH) receptor: conditional efficacy of PTH peptide fragments.
    Sneddon WB; Magyar CE; Willick GE; Syme CA; Galbiati F; Bisello A; Friedman PA
    Endocrinology; 2004 Jun; 145(6):2815-23. PubMed ID: 15016722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca
    White AD; Fang F; Jean-Alphonse FG; Clark LJ; An HJ; Liu H; Zhao Y; Reynolds SL; Lee S; Xiao K; Sutkeviciute I; Vilardaga JP
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3294-3299. PubMed ID: 30718391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
    Yang Y; Wang B
    Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Arrestin-biased signaling of PTH analogs of the type 1 parathyroid hormone receptor.
    van der Lee MM; Verkaar F; Wat JW; van Offenbeek J; Timmerman M; Voorneveld L; van Lith LH; Zaman GJ
    Cell Signal; 2013 Feb; 25(2):527-38. PubMed ID: 23159578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
    Vilardaga JP; Lin I; Nissenson RA
    Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption.
    Bohinc BN; Gesty-Palmer D
    Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):112-9. PubMed ID: 21476967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating in vitro ligand bias into in vivo efficacy.
    Luttrell LM; Maudsley S; Gesty-Palmer D
    Cell Signal; 2018 Jan; 41():46-55. PubMed ID: 28495495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.
    Vilardaga JP; Romero G; Friedman PA; Gardella TJ
    Cell Mol Life Sci; 2011 Jan; 68(1):1-13. PubMed ID: 20703892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.